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Ortiz-Baza´n et al. now show that toler-
ance to methyl methanesulfonate
(MMS)-induced DNA lesions during S
phase is carried out mainly by Rad5-
mediated, error-free damage bypass.
Rad5 allows the progression of replica-
tion forks through MMS-damaged DNA,
ensuring the completion of chromosome
replication while minimizing mutagen-
esis, all of which are crucial for genome
stability.
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The RAD6/RAD18 pathway of DNA damage toler-
ance overcomes unrepaired lesions that block repli-
cation forks. It is subdivided into two branches:
translesion DNA synthesis, which is frequently error
prone, and the error-free DNA-damage-avoidance
subpathway. Here, we show that Rad5HLTF/SHPRH,
which mediates the error-free branch, has a major
role in the response to DNA damage caused by
methyl methanesulfonate (MMS) during chromo-
some replication, whereas translesion synthesis
polymerases make only a minor contribution. Both
the ubiquitin-ligase and the ATPase/helicase activ-
ities of Rad5 are necessary for this cellular response.
We show that Rad5 is required for the progression
of replication forks through MMS-damaged DNA.
Moreover, supporting its role during replication, this
protein reaches maximum levels during S phase
and forms subnuclear foci when replication occurs
in the presence of DNA damage. Thus, Rad5 ensures
the completion of chromosome replication under
DNA-damaging conditions while minimizing the risk
of mutagenesis, thereby contributing significantly
to genome integrity maintenance.INTRODUCTION
The conserved RAD6/RAD18 pathway of DNA damage toler-
ance (DDT) plays a crucial role in genome stability, allowing the
bypass of unrepaired DNA lesions that hamper replication forks
(Branzei, 2011; Chang and Cimprich, 2009; Saugar et al., 2014;
Ulrich, 2011). This pathway can be subdivided into two
branches: translesion DNA synthesis (TLS) and the damage-
avoidance subpathway. TLS uses specialized, low-fidelity DNA
polymerases that can replicate directly across the lesions in a
frequently mutagenic process (Sale, 2013). In contrast, the dam-
age-avoidance branch mediates damage bypass by transient
template switching, in which the blocked DNA nascent strand
uses the newly synthesized, undamaged strand of the sister
chromatid as a template for replication over the DNA lesion, in
a process that is error free (Branzei, 2011; Ulrich, 2011). In460 Cell Reports 9, 460–468, October 23, 2014 ª2014 The Authorsbudding yeast, damage avoidance is mediated by the E3-
ubiquitin ligase Rad5 (HLTF and SHPRH in humans), a protein
that also has ATPase activity, together with the E2-conjugating
complex Mms2-Ubc13UEV1 (Unk et al., 2010). DDT mechanisms
are controlled by posttranslational modifications of proliferating
cell nuclear antigen (PCNA), the processivity factor for DNA
polymerases (Branzei, 2011; Chang and Cimprich, 2009;
Saugar et al., 2014; Ulrich, 2011). Thus, in response to many
types of DNA damage or replicative stress, PCNA is monou-
biquitylated by Rad6/Rad18, leading to the recruitment of
TLS polymerases. PCNA can be further polyubiquitylated by
Rad5HLTF/SHPRH-Mms2-Ubc13UEV1, triggering the damage-
avoidance subpathway.
Although the two branches of the RAD6/RAD18 pathway
adopt distinct strategies for damage bypass, one might expect
that to avoid mutagenesis, the error-free subpathway would be
generally favored. However, this preference is not obvious, and
little is known about how cells choose between TLS and tem-
plate switching. This choice appears to depend on the nature
of the DNA lesions as well as on the extent of the damage or
the timing of the cellular response. For example, in human cells,
DNA lesions induced by UV light or tobacco smoke are preferen-
tially bypassed by TLS (Izhar et al., 2013). In budding yeast, DNA
lesions induced by acute exposure to UV light are mainly
bypassed by TLS (Daigaku et al., 2010), but damage avoidance
ismore important during chronic low-dose UV exposure (Hishida
et al., 2009). Likewise, either branch of RAD6/RAD18 is sufficient
for cell survival after treatment with a low dose of methyl metha-
nesulfonate (MMS), but the preferential use of one over the other
is cell-cycle dependent (Huang et al., 2013). Interestingly, DNA
bending facilitates template switching, revealing that chromatin
architecture is also a fundamental factor that influences the
mode of DDT (Gonzalez-Huici et al., 2014).
Another key issue in the function of DDT mechanisms is when
andwhere they operate (i.e., coupled to replication forks or post-
replicatively). There is convincing evidence that TLS and damage
avoidance function behind replication forks, probably promoting
gap filling (Branzei et al., 2008; Daigaku et al., 2010; Huang et al.,
2013; Karras and Jentsch, 2010; Lopes et al., 2006). However,
the Rad5-dependent, error-free branch may facilitate the restart
of forks stalled by DNA damage, at least near replication origins
(Minca andKowalski, 2010). Also in favor of a possible fork-asso-
ciated process, Rad5 and HLTF have been shown to promote
fork regression in vitro (Blastya´k et al., 2007, 2010), although it
is unknown whether this also occurs in vivo.
Here, we analyze the contribution of the two branches of the
RAD6/RAD18 pathway to the tolerance to replication-blocking
DNA lesions, using budding yeast and themodel DNA-damaging
agent MMS. We show that the Rad5-dependent DNA damage-
avoidance subpathway performs the principal role in this cellular
response and that Rad5 has a key function at forks, allowing
replication through damaged DNA.
RESULTS
Tolerance toMMS-Induced DNA Lesions during S Phase
Is Carried Out Predominantly by the Rad5-Dependent
Damage-Avoidance Pathway
To assess the relative contributions of the two branches of the
RAD6/RAD18 pathway to chromosome replication over DNA
lesions, we limited DNA damage to a single S phase and studied
the consequences of a lack of TLS polymerases or Rad5. Control
and mutant cells were synchronized in G1 and released into
medium with or without 0.033% MMS. In the absence of MMS,
all cells completed S phase by 60 min and continued cycling,
whereas they progressed slowly through S phase in medium
with MMS due to the DNA lesions (Paulovich and Hartwell,
1995; Tercero and Diffley, 2001; Figure 1A). Flow-cytometry
analysis indicated no apparent differences between wild-type
(WT) and tlsD (rev3Drad30Drev1D) cells in S-phase progression
when the cells were treated with MMS. However, rad5D cells
showed increased defects and, unlike WT or tlsD cells, most of
these cells did not reach a 2C DNA content (Figure 1A). Lack
of TLS polymerases or Rad5 did not cause replication perturba-
tions per se, as the S-phase checkpoint was not activated if cells
were not exposed to DNA damage. After MMS exposure, the
checkpoint was activated normally in all strains, as Rad53 was
phosphorylated and acquired kinase activity (Figure 1A).
We repeated the above experiment with a much lower dose
of MMS (0.0033%) that neither delayed cell-cycle progression
nor activated Rad53 in WT cells (Figure 1B). tlsD cells were
also unaffected by exposure to 0.0033% MMS, as they cycled
normally and did not activate Rad53 (Figure 1B). However, the
same treatment impeded the progression of rad5D cells
through the cell cycle, and cells remained blocked with a 2C
DNA content as large budded cells with undivided chromatin
(Figures 1B and S1). Furthermore, in contrast to WT and tlsD
cells, Rad53 was activated in rad5D cells (Figure 1B). Although
rad5D cells reached a 2C DNA content, checkpoint activation
was due to problems during replication, since when the cells
were blocked in G2/M and then treated with 0.0033% MMS,
neither Rad53 phosphorylation nor Rad53 kinase activity was
triggered (Figure S1). These results identify a crucial function
for Rad5 in the response to MMS-induced DNA damage during
S phase.
We next examined cell viability upon treatment with several
concentrations of MMS during S phase. Whereas WT cells
showed high viability and tlsD cells were only moderately sensi-
tive at the highest MMS doses, rad5D cells exhibited a dramatic
drop in viability after MMS treatment and were sensitive to the
lowest MMS dose (Figure 1C). rad5D showed a slightly less
marked loss of viability than rad18D, whereas tlsDrad5D and
rad18D cells showed a similar viability (Figure 1C), suggestingCthat the extreme sensitivity of Rad18-deficient cells to MMS is
due to the lack of Rad5 and TLS functions. Thus, both branches
of the RAD6/RAD18 pathway are important for dealing with
MMS-induced DNA lesions during S phase. However, it is clear
that the DNA damage-avoidance branch, mediated by Rad5,
has the major role in this response and TLS makes only a minor
contribution.
Rad5 Is Required for the Progression of Replication
Forks through Damaged DNA
The above data indicate a central role for Rad5 in tolerance to
MMS-induced DNA damage during S phase, pointing to an
important function of this protein in replication of damaged chro-
mosomes. However, it was previously proposed that rad5D cells
could replicate through MMS-damaged DNA without delay (Kar-
ras and Jentsch, 2010). To analyze chromosome replication
under these DNA-damaging conditions, we used dense isotope
transfer, which allows one to study ongoing DNA synthesis at a
specific replicon by analyzing the movement of replication forks
(Tercero et al., 2000).
WT, tlsD, and rad5D cells were grown in medium with ‘‘heavy’’
isotopes, synchronized in G1, and released into medium with
‘‘light’’ isotopes, either with or without MMS. The replication of
six DNA fragments was followed in a replicon of chromosome
VI (Tercero and Diffley, 2001) from the ARS607 origin to the
end of the chromosome (Figure 2). All DNA fragments were in
the ‘‘heavy-heavy’’ (HH; unreplicated DNA) peak in G1 cells
(top row). In all cases, DNA fragments shifted to the ‘‘heavy-light’’
(HL; replicated DNA) peak by 60 min in medium without MMS
(bottom row), indicating that they had been replicated. In WT
cells, fragment 1 containing ARS607 shifted to the HL peak by
30 min following release into medium with MMS, and some HL
DNA was also apparent in fragment 2 (Figure 2A). DNA replica-
tion advanced rightward: fragment 3 shifted to the HL position
by 60 min and replication of the remaining fragments proceeded
progressively (replication is quantified in Figure 2D). Thus, as
described previously (Tercero and Diffley, 2001; Va´zquez et al.,
2008), the forks progressed slowly through damaged DNA but
were able to replicate the entire replicon. Fork progression in
the presence of MMS in tlsD cells was similar to that in WT cells:
fragments 1 and 2 shifted to the HL peak by 30 min; forks pro-
gressed slowly from left to right, and by 240 min the replicon
was mostly replicated (Figures 2B and 2D). Thus, TLS polymer-
ases are not required for fork progression through MMS-
damaged DNA.
In the rad5D mutant, the DNA fragment 1 shifted to the HL
peak by 30 min in medium containing MMS (Figure 2C), showing
that ARS607 fired as in WT cells. Forks moved slowly and DNA
replication advanced rightward, as indicated by the progressive
shifting of the restriction fragments to the HL peak. However,
there were notable differences between rad5D and WT cells.
Thus, the percentage of replicated (HL) DNA of fragments 2–6
at 120 min was markedly reduced in the rad5D mutant in com-
parison with WT cells (Figures 2C and 2D). At 240 min, when
the replicon was mostly replicated in WT cells, a considerable
amount of DNA remained unreplicated (HH peak) in fragments
2–6 in rad5D cells. Indeed, only about 25% of the forks had
reached the end of the replicon at the latest time pointmeasured.ell Reports 9, 460–468, October 23, 2014 ª2014 The Authors 461
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Figure 1. Rad5 Has a Major Role in Tolerance to MMS-Induced DNA Lesions during S Phase
(A and B) WT (YMO13 strain), tlsD (YMO27), and rad5D (YMO18) cells were blocked in G1 using a-factor and released into medium ± 0.033% MMS (A)
or ± 0.0033% MMS (B). Upper panel: DNA content was determined by flow cytometry to follow cell-cycle progression. Bottom panel: immunoblot and in situ
autophosphorylation analysis of Rad53.
(C) G1-blocked cells were released into S phase in the presence of different MMS concentrations. Cell viability was estimated at the indicated time points. rad18D
(YJT116 strain); tlsDrad5D (YMO28).
See also Figure S1.
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Figure 2. Rad5 Is Required for DNA Replication Fork Progression through Damaged DNA
(A–C) The progression of DNA replication forks was analyzed by density transfer. (A) WT (YMO13 strain), (B) tlsD (YMO27), and (C) rad5D (YMO18) cells were
blocked in G1 with a-factor in medium with heavy isotopes and then released into medium with light isotopes ±MMS (0.033%). Fork progression was followed in
a replicon of chromosome VI using probes that recognize the ClaI/SalI fragments 1–6 (Tercero and Diffley, 2001). The relative amounts of radioactivity in the
hybridized DNA are plotted against the gradient fraction number. Unreplicated (HH) and fully replicated (HL) peaks are indicated. The position of the initial HH
peak is shown for comparison (gray area). Solid arrows indicate persistent unreplicated DNA in rad5D cells. The dashed arrow indicates the small amount of
replicated DNA in rad5D cells at the end of the replicon at the latest time point (fragment 6, 240 min).
(D) Quantification of DNA replication in the presence of MMS for every DNA fragment and time point.
See also Figures S1 and S3.Remarkably, the percentage of replicated DNA (65%) in frag-
ments 2 and 3 did not further increase after 60 min, indicating
that a significant fraction of forks stalled or collapsed before
passing them. The average size of a replicon in budding yeast
is 40 kb and thus forks normally travel 20 kb. We estimated
that about one-third of the forks terminated before 20 kb fromCtheARS607 origin in rad5D cells after 240min of MMS treatment.
Therefore, these results show that Rad5 is necessary for the
extensive progression of replication forks through MMS-
damaged DNA. Moreover, these data could explain why rad5D
cells lose viability when treated with MMS during S phase
(Figure 1C).ell Reports 9, 460–468, October 23, 2014 ª2014 The Authors 463
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Figure 3. Rad5-Ubiquitin Ligase and ATPase/Helicase Activities Are Required for the DNA Damage Response during S Phase
(A and B) (A) rad5-I916A cells (YMO60 strain) and (B) rad5-GAA cells (YMO57 strain) were blocked in G1 using a-factor and released intomedium ±MMS (0.033%
or 0.0033%). Upper panel: cell-cycle progression was followed by flow cytometry. Bottom panel: immunoblot and in situ autophosphorylation analysis of Rad53.
(C) G1-blocked cells were released into S phase in medium containing different concentrations of MMS. Cell viability was estimated at the indicated time points.
The strains (all isogenic) were RAD5+ control (YMO56 strain), rad5-I916A (YMO60), ubc13D (YMO69), rad5-GAA (YMO57), rad5-I916A/GAA (YMO63), rad5-
GAAubc13D (YMO71), and rad5D control (YMO55).
See also Figures S2 and S3.The Ubiquitin-Ligase and ATPase/Helicase Activities of
Rad5 Are Required for the Response to MMS-Induced
DNA Damage during S Phase
To determine the contribution of the known activities of Rad5 to
the response to MMS-induced DNA lesions, we generated
strains harboring RAD5mutations that eliminate either its ubiqui-
tin-ligase activity (rad5-I916A) (Ulrich, 2003) or ATPase activity
(rad5-K538A/T539A, or rad5-GAA) (Chen et al., 2005; Figure S2),
and then we used the same approach described above.
rad5-I916A and rad5-GAA cells cycled normally, but in com-
parison with WT and tlsD cells, S-phase progression was
delayed in the presence of 0.033% MMS (Figures 1A, 3A, and
3B). When exposed to 0.0033% MMS, a dose that does not
affect WT or tlsD cells (Figure 1B), the rad5-I916A and rad5-
GAA mutants could not progress through the cell cycle and,
like the rad5D cells (Figure 1B), remained blocked with a 2C
DNA content (Figures 3A and 3B). Moreover, Rad53 was phos-
phorylated and acquired kinase activity, indicating checkpoint
activation at this low MMS dose (Figures 3A and 3B), mirroring
the results with rad5D (Figure 1B). Consistently, a ubc13D strain,
in which PCNA cannot be polyubiquitylated due to defective E2-464 Cell Reports 9, 460–468, October 23, 2014 ª2014 The Authorsubiquitin conjugating activity, behavedas rad5-I916A (FigureS2).
Therefore, the ubiquitin-ligase and ATPase activities of Rad5 are
important for its functional response to MMS. Strengthening this
conclusion, density transfer experiments showed that rad5-
I916A, rad5-GAA, and ubc13D mutants were defective in fork
progression through MMS-damaged DNA (Figure S3).
In support of our conclusion that ubiquitin-ligase and ATPase
activities are required for tolerance to MMS-induced DNA
lesions, both rad5-I916A and rad5-GAA mutants lost viability
significantly in comparison with an isogenic RAD5+ control strain
when treated with 0.01% or 0.033% MMS during S phase (Fig-
ure 3C). Also, the viability of an isogenic ubc13D strain was
similar to that of rad5-I916A. The decrease in viability of these
rad5 mutants was not as extreme as that found for rad5D cells;
thus, we constructed a double rad5-I916A/GAA mutant to
assess whether the effects of lacking both activities were syner-
gistic. As shown in Figure 3C, rad5-I916A/GAA cells did not pre-
sent increased sensitivity to MMS with respect to the most
sensitive individual mutant, rad5-GAA. In agreement with the
above data, the sensitivity of the rad5-GAAubc13D strain was




Figure 4. Rad5 Regulation
(A) RAD5-HA cells (YMO52 strain) were synchronized in G1 and then released into fresh medium. Cell-cycle progression was analyzed by flow cytometry (left).
The percentage of budded and binucleated cells was estimated throughout the experiment (right). Rad5 immunoblot analysis is shown below. The relative protein
levels are depicted for every time point.
(B) G1-synchronized RAD5-HA cells (YMO52 strain) were released into medium ±MMS (0.033%). Cell-cycle progression was analyzed by flow cytometry (upper
panel, left). Immunoblot analysis of Rad5 (bottom panel). The relative protein levels are depicted (upper panel, right).
(C) GFP-RAD5 cells (YMO36 strain) were synchronized in G1 using a-factor, released into S phase in medium either without MMS (for 30 min) or with 0.033%
MMS (for 60 min), and analyzed by fluorescence microscopy.
(D) Percentage of cells with GFP-Rad5 foci under several conditions and in different mutants. For MMS treatment, cells were blocked in G1, released into S phase
and exposed to 0.033%MMS for 60 min, or treated for 60 min with 0.033% once they were blocked in G2/M. UV-treated cells were analyzed 30 min (in the dark)
after 200 J/m2 UV exposure in G1 and release into S phase. Cells were treated with 1 mM H202 for 30 min after release into S phase from a G1 block. Cells were
treated with 0.2 M HU for 120 min after release from a G1 block. The histograms represent the mean ± SD from three independent experiments.
See also Figure S4.terms of tolerance to MMS, rad5-I916A and rad5-GAA mutants
are epistatic, suggesting that the Rad5 ubiquitin-ligase and
ATPase/helicase actions work sequentially and not indepen-
dently. The fact that rad5-I916A/GAA cells are less sensitive to
MMS than the isogenic rad5D control (Figure 3C) could be ex-
plained by additional Rad5 functions in DDT. In this regard,
Rad5 controls some TLS events (Coulon et al., 2010; Gangavar-
apu et al., 2006; Page`s et al., 2008), and its human homologs,
HLTF and SHPRH, promote the recruitment of the most appro-
priate TLS polymerase to the sites of damage (Lin et al., 2011).
Rad5 Is a Periodic Protein that Peaks in S Phase and, in
Response to DNA Damage, Forms Subnuclear Foci
To study the potential regulation of Rad5, we first analyzed its
expression throughout the cell cycle. RAD5-HA cells were syn-
chronized in G1, released, and allowed to cycle. Rad5 expres-Csion oscillated significantly along the cell cycle (Figure 4A).
Thus, Rad5 reached maximum levels at 20–30 min after G1
release, indicating a peak of expression in early-mid S phase.
Thereafter, protein levels decreased and reached a minimum
at the end of S phase or mitosis (50–70min after G1), rising again
during the S phase of the second cell cycle (90min) (Figure 4A).
This result strongly suggests that Rad5 acts predominantly dur-
ing S phase, and is consistent with its role in chromosomal repli-
cation in the face of DNA damage. Similar results were obtained
with Rad5-GFP, eliminating the possibility that the observed
oscillations were due to the epitope tag used (Figure S4).
To study whether Rad5 was regulated in response to DNA
damage, we released G1-blocked cells into S phase in medium
with and without MMS (Figure 4B). In drug-free medium, Rad5
oscillated as before. In medium containing MMS, Rad5 showed
maximum levels that were similar to those reached in theell Reports 9, 460–468, October 23, 2014 ª2014 The Authors 465
absence of DNA damage. Further, these levels were maintained
during the experiment due to the prolonged S phase. Thus, MMS
treatment during S phase does not significantly influence Rad5
levels. Therefore, Rad5 expression is independent of exogenous
DNA damage.
We next analyzed Rad5 in vivo by fluorescence microscopy.
In untreated cells, Rad5 appeared spread in the nucleus, but
it accumulated and formed subnuclear foci after exposure to
0.033% MMS during S phase (Figure 4C). These foci were
visible in approximately 80% of the cells (quantification is
shown in Figure 4D) and usually appeared as one or two
discrete dots per cell (Figure 4C). Therefore, Rad5 relocalized
within the nucleus in response to MMS-induced DNA damage,
even though its levels did not show significant changes after
MMS exposure (Figure 4B). Rad5-foci formation was clearly
seen in S phase, but was not detected in G2/M-blocked cells
treated with MMS (Figures S4 and 4D), supporting a function
for Rad5 during S phase. The ubiquitin-ligase and ATPase/
helicase activities of Rad5 were not required for formation of
these foci (Figures S4 and 4D), signifying that this response is
independent of its catalytic activity. Rad5 relocalization also
occurred after treatment with other DNA-damaging agents,
such as H2O2 (Figures S4 and 4D). However, no foci were
detected after UV light exposure (Figures S4 and 4D), presum-
ably because TLS is more important than damage avoidance for
tolerance to acute UV treatment (Daigaku et al., 2010). In a
recent high-throughput screening, Tkach et al. (2012) identified
Rad5 as one of the proteins that showed localization changes
following drug-induced replication stress. Our results agree
with and extend their data regarding Rad5 relocalization upon
exposure of asynchronously growing cells to 0.03% MMS, but
differ from their data suggesting that Rad5 foci formed after
treatment with 0.2 M hydroxyurea (HU). In our strains, we could
not detect Rad5 foci when cells were treated with 0.2 M HU
after release from a G1 block (Figures S4 and 4D). Analogously
to MMS, 0.2 M HU causes fork stalling (Tercero et al., 2000), but
unlike MMS, it does not necessarily invoke DNA damage.
Therefore, only fork blocks caused by some DNA lesions lead
to Rad5 foci formation. Interestingly, the formation of DNA-
damage-induced Rad5 foci is Rad18 independent, as they
were detected in MMS-treated rad18D cells (Figures S4 and
4D). Also, Rad5 foci formation does not require the activation
of the S phase checkpoint triggered by MMS, as they also
appeared in the checkpoint-deficient strains mec1D and
rad53D after exposure to this drug (Figures S4 and 4D).
DISCUSSION
We show in this work that the DNA damage-avoidance branch of
the RAD6/RAD18 pathway, mediated by Rad5, has the principal
role in tolerance to MMS-induced DNA lesions during chromo-
some replication. This choice ensures an error-free process
and minimizes the risk of mutagenesis. Interestingly, cells
respond differently to another commonly used DNA-damaging
treatment, acute UV exposure, because TLS is the main mecha-
nism of lesion bypass in this case (Daigaku et al., 2010). Similarly,
human cells also preferentially use TLS in response to environ-
mental agents (Izhar et al., 2013). These data demonstrate that466 Cell Reports 9, 460–468, October 23, 2014 ª2014 The Authorscells employ different efficient strategies to tolerate diverse
DNA insults.
Our results show that the Rad5-mediated cellular response
allows chromosome replication under conditions of DNA dam-
age. Both the ubiquitin-ligase and ATPase/helicase activities of
Rad5 are required for this process. We show that Rad5 is
required for fork progression through MMS-damaged DNA, indi-
cating a direct role for this protein at forks. However, DDT mech-
anisms are operational after the bulk of genome replication has
been completed (Daigaku et al., 2010; Karras and Jentsch,
2010), which together with other findings indicates that they
could function postreplicatively, behind replication forks (Branzei
et al., 2008; Daigaku et al., 2010; Huang et al., 2013; Karras and
Jentsch, 2010; Lopes et al., 2006). Regardless of whether this
pathway operates at forks or postreplicatively, it is likely that
Rad5 acts through a recombinational mechanism in both cases,
originating X-shaped DNA structures that involve sister chro-
matid junctions (Branzei et al., 2008; Minca and Kowalski,
2010). Nevertheless, the fact that Rad5 can work at forks leaves
open the possibility that it can also promote fork regression
(Blastya´k et al., 2007). Taking all of these considerations into
account, we propose that the Rad5-dependent, error-free
branch of the RAD6/RAD18 pathway operates normally during
S phase and that its action can occur both directly at forks and
in the rear of continuing replication, which might depend upon
the types of lesions or the particular sites of damage. The
mode of action of Rad5 reflects a robust system of DNA damage
avoidance that can function even after bulk DNA synthesis.
Consistent with its role in promoting fork progression through
damaged DNA, we found that Rad5 has a peak of expression
during S phase. This regulation is different from that of other
DDT proteins, such as Rev1, whose levels peak in G2/M (Waters
and Walker, 2006), supporting a TLS function after bulk DNA
replication. We also show that in response to MMS, Rad5 accu-
mulates and forms subnuclear foci in S phase. This relocalization
is Rad18 independent, which would be in agreement with the in-
dependent association of Rad18 and Rad5 to chromatin despite
their colocalization (Ulrich and Jentsch, 2000). In addition, we
found that Rad5 foci are also formed in the absence of the
S phase checkpoint, which indicates independent signaling
pathways. Together, our results extend our understanding of
how the Rad5-dependent pathway is regulated in response to
DNA lesions. As a consequence of some types of DNA damage,
Rad18 is recruited to chromatin, Rad5 is independently relocal-
ized and forms subnuclear foci in S phase, and its E2 ubiquitin-
conjugating counterparts Ubc13 and Mms2 relocalize from the
cytoplasm to the nucleus (Ulrich and Jentsch, 2000), with all of
these processes occurring in parallel but independently of
checkpoint activation. It is possible that accumulation of Rad5
facilitates its interaction with Rad18 and Ubc13/Mms2, as well
as its access to DNA lesions, thereby contributing to the
damage-avoidance process.
Rad5 is critical for genome integrity. It sidesteps mutagenesis,
which is directly related to cancer development. Indeed, the
RAD5 human orthologs HLTF and SHPRH are inactivated in
some cancer cells (Debauve et al., 2008; Sood et al., 2003). An
extrapolation of the results from this work would imply that
some tumor cells could be extremely sensitive to drugs that
interfere with DNA replication due to defects in the error-free
branch of the RAD6/RAD18 pathway. This scenario could be
explored to improve chemotherapy strategies.
EXPERIMENTAL PROCEDURES
Strains and Media
The yeast strains used in this work are listed in Table S1. Yeasts were routinely
grown in YP medium with 2% glucose.
Cell-Cycle Blocks, Flow Cytometry, Cell Viability, and Microscopy
a-Factor (5–10 mg/ml) was used for G1 synchronization. Flow cytometry was
performed as previously described (Va´zquez et al., 2008). Cell viability was
determined by plating cells in triplicate and counting colony-forming units after
3 days of incubation at 30C. The numerical data are the average of compara-
ble experiments. For fluorescence microscopy, cells were grown in minimal
medium supplemented with yeast synthetic dropout. Live cells were analyzed
using an Axiovert 200 fluorescence microscope (Zeiss). The percentage of
cells containing foci was estimated after analyzing three independent experi-
ments, and at least 300 cells were counted in each experiment.
Immunoblotting and In Situ Kinase Assays
Protein extracts were prepared from trichloroacetic acid-treated cells (Va´z-
quez et al., 2008). Hemagglutinin-tagged proteins were detected with the
12CA5 antibody (CBMSO) and GFP-tagged proteins were detected with an
anti-GFP antibody (Roche). Anti-Actin antibody was obtained from MP
Biomedicals. The secondary antibody was horseradish peroxidase (HRP)-
coupled anti-mouse (Vector Labs). Rad53 was detected with the JDI48
antibody (J. Diffley, Cancer Research UK) using HRP-coupled Protein A
(Invitrogen) as a secondary antibody. Quantification of protein bands was car-
ried out using a GS-800 densitometer (BioRad) and density was normalized to
actin. The Rad53 in situ kinase assay was performed as described previously
(Va´zquez et al., 2008).
Dense Isotope Transfer
Density transfer assays were performed as previously described (Tercero
et al., 2000). The extent of replicationwas calculated as follows:% replication =
100(0.5 HL/(HH+0.5 HL)).
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